All In MedTech

Device Trial Radar · NCT05090748

Study for the Assessment of the Quality of Echocardiographic Clips.

A Pivotal Study for the Assessment of the Quality of Echocardiographic Clips When Obtained by Novice Users While Using the UltraSight Echocardiography Guidance (USEG) Software.

Last checked: Nov 19, 2026Latest source record: Dec 7, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

240

Actual

Start

May 15, 2022

Primary completion

Aug 5, 2022

Study completion Aug 31, 2022

Sponsor

Lead sponsor
UltraSightNot on our public-company list
Sponsor type
Industry
First posted
Oct 25, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 120 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study main objective is to evaluate the safety and efficacy of the UltraSight AI Guidance software. The investigational product is a software that guides the user to capture a high quality ultrasound image. The study will include healthcare professionals, not specialized in echocardiography, who will perform echocardiography by using UltraSight AI Guidance software, on subjects in the medical centers cardiac units.

Conditions

  • Cardiac Disease

Interventions

  • Echocardiographic.Device

    Echocardiographic test.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of the echo examination sufficiency.Time frame: 1 year.

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Chicago Medicine

    Chicago, Illinois

  • Aurora St. Luke's Medical Center

    Milwaukee, Wisconsin

  • Sheba MC

    Ramat Gan, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.